Syros Pharmaceuticals (LTS:0LC7) Short Interest


LTS:0LC7 Syros Pharmaceuticals Inc LTS:0LC7
12 GF Score
Price $0.00
View Full Analysis

What is Syros Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0LC7 vs AFMDQ, BTAX, TRVN: Short Interest Comparison

For the Biotechnology subindustry, Syros Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syros Pharmaceuticals Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syros Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Syros Pharmaceuticals's Short Interest falls into.


LTS:0LC7
12GF Score
Syros Pharmaceuticals Inc LTS:0LC7
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syros Pharmaceuticals Business Description

Address 35 CambridgePark Drive, 4th Floor, Cambridge, MA, USA, 02140
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
12GF Score

Get the complete analysis for LTS:0LC7

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price